Volume 69, Issue 5 pp. 603-605
Note

Analysis of mepivacaine, bupivacaine, etidocaine, lidocaine, and tetracaine

George B. Park

George B. Park

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144

Search for more papers by this author
Paul E. Erdtmansky

Paul E. Erdtmansky

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144

Search for more papers by this author
Richard R. Brown

Richard R. Brown

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144

Search for more papers by this author
M. Peter Kullberg

M. Peter Kullberg

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144

Search for more papers by this author
Jerome Edelson

Corresponding Author

Jerome Edelson

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144

Department of Drug Metabolism and Disposition, Sterling-Winthrop Research Institute, Rensselaer, NY 12144Search for more papers by this author
First published: May 1980
Citations: 1

Abstract

A GLC method, employing a nitrogen–phosphorus-sensitive detector, is described for the analysis of mepivacaine, bupivacaine, etidocaine, lidocaine, and tetracaine in biological fluids. The method is simple, reliable, and sensitive, with a practical limit of sensitivity of ∼2.5 ng/ml, well below therapeutic plasma levels. Extensive start-up procedures and sample preparation are not required.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.